最近肠道微生物组的进展介绍了阻塞性睡眠呼吸暂停引起的心血管疾病
Xiaotong Zhang1, Haifen Zhang1, Shuai Li1
1Shanxi Provincial People's Hospital The Fifth Clinical Medical College of Shanxi Medical University Taiyuan China.
FASEB bioAdvances
|April 8, 2024
概括
阻塞性睡眠呼吸暂停 (OSA) 与心血管疾病有关,但机制尚不清楚. 准肠道微生物群可能为患有高血压的OSA患者提供新的治疗方法.
科学领域:
- 睡眠医学 睡眠医学
- 心脏病学 心脏病学
- 微生物组研究 微生物组研究
背景情况:
- 阻塞性睡眠呼吸暂停 (OSA) 是一种常见的疾病,与心血管疾病 (CVD) 风险增加有关,特别是高血压.
- 像CPAP这样的当前治疗方法有合规问题,OSA相关心血管疾病的替代疗法有限.
- 肠道微生物组在OSA病理生理学中的作用及其对相关心血管疾病的影响正在引起人们的注意,但需要进一步阐明.
研究的目的:
- 审查最近关于肠道微生物组与OSA的联系的研究.
- 澄清连接肠道微生物组,OSA和OSA相关心血管疾病的机制,重点关注高血压.
- 探索肠道微生物向疗法的潜在益处,作为OSA的辅助治疗.
主要方法:
- 最近研究的文献综述.
- 分析肠道微生物组变化与OSA之间的关联.
- 检查肠道微生物对OSA相关心血管并发症,特别是高血压的影响.
主要成果:
- 越来越多的证据表明,肠道微生物组失调和OSA之间存在显著的相关性.
- 肠道微生物组影响OSA相关心血管疾病的发展和严重程度,包括高血压.
- 特定的微生物形状与OSA及其心血管后果有关.
结论:
- 肠道微生物组代表着一个有前途的治疗目标,用于管理OSA及其相关的心血管风险.
- 需要进一步的研究才能充分理解肠道微生物群,OSA和CVD之间的复杂相互作用.
- 针对肠道微生物组的辅助疗法可能会改善OSA和高血压患者的结果.
相关概念视频
01:21Sleep Apnea
148
Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
The condition is more prevalent among...
148
01:17Other Pulmonary Disorders
836
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
836
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K
01:22Chronic Obstructive Pulmonary Disease
1.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K
01:13Insufficient Sleep and Sleep Deprivation
141
Insufficient sleep refers to not getting the recommended amount of sleep for optimal functioning, even if it's just slightly less than needed. Sleep insufficiency may occur due to lifestyle choices, such as staying up late for social events or work, resulting in routinely getting less sleep than required. For example, consistently sleeping 6 hours when the body needs 7-9 hours can lead to cumulative effects on health and well-being.
Sleep deprivation is a more severe form of sleep loss...
Sleep deprivation is a more severe form of sleep loss...
141